Registry Study for Minos™ Stent-Graft in Abdominal Aortic Aneurysm Treatment Launched
A post-market registry study has been initiated to evaluate the Minos™ Stent-Graft's safety and performance in real-world settings.
Phase III
Cardiovascular / Abdominal Aortic Aneurysm
Status
Initiated
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The initiation of the post-market registry study for the Minos™ Stent-Graft is significant as it aims to gather real-world safety and performance data, which could impact its market adoption. Monitoring the outcomes will be crucial for understanding competitive positioning in the aortic aneurysm treatment landscape.
Recommended action
Humanexa recommends Monitor.
Analysis
Key milestones include patient enrollment progress and interim safety data releases from the registry.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.